ArticleFEBS open bio2026
Multi-omics and low-input proteomics profiling reveals dynamic regulation driving pluripotency initiation in early mouse embryos.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pre-implantation of a mouse embryo is a process of transitioning from totipotency to pluripotency. However, the regulatory mechanisms underlining this transition remain poorly understood. We combined single-cell transcriptomic analysis, epigenetic profiling, low-input proteomics and functional validation experiments with the aim of gaining insight into the dynamic regulatory networks underlying the transition from the eight-cell to the 16-cell stage of mouse development. Transcriptomic analysis and H3K4me3 modification profiling, combined with functional half of the blastomeres biopsy, revealed that eight-cell mouse embryos retained residual totipotency-related molecular features and developmental potential. Furthermore, we identified dynamic cytoskeletal remodeling, regulated in part by the ubiquitin-proteasome system, as a prominent molecular event during the transition from the eight-cell to the 16-cell stage. Collectively, our findings highlight the eight-cell stage as a critical developmental window characterized by gradual restriction of developmental potential, and also underscore cytoskeletal remodeling as a key molecular process coinciding with the onset of pluripotency. These results provide insight into the biological processes underlying totipotent features and how these are progressively attenuated during early mouse embryogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.